Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dengzhan Shengmai capsule for secondary prevention of ischemic stroke
NCT00548223Phase 4Completed
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Dec 2007
- Primary completion
- Jan 2011
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 4 trial of Dengzhan Shengmai in ischemic stroke, sponsored by Guangzhou University of Chinese Medicine. Started Dec 2007; status: completed.
02
Drugs
Dengzhan Shengmai
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00548223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548223.